ReviewFrontiers in immunology2024
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target.
Marsha Pellegrino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it